Company Long-Term Loans and Borrowings: MindWalk (HYFT)

Public company logo of MindWalk (HYFT)

MindWalk Holdings (HYFT) utilizes neural network algorithms for the rapid selection of biomarkers and drug development. Business growth is driven by the implementation of the BioStrand system, the expansion of the B2B segment, and an influx of high-margin software payments. However, a lack of profitability and R&D expenditures are creating financial stress, with long-term debt amounting to 0.00. This market price chart below illustrates the asset's price action against the backdrop of reserve depletion.

HYFT MindWalk Holdings Company Long-Term Debts (09/05/2025 - 11/01/2026)
Brand item of MindWalk Holdings Inc.

For MindWalk Holdings, which is developing AI automation during a market formation period, long-term liabilities serve as an indicator of financial leverage while scaling its customer base. By analyzing the company's long-term debt history, an investor can see the volume of loans with maturities exceeding one year, allowing for an assessment of balance sheet stability and the risk of overleveraging the asset with borrowed capital prior to potential merger and acquisition deals.

Who MindWalk Holdings competes with

Company Long-Term Debts haleon.com HLN|KVUE - Company Long-Term Debt|Company Long-Term Loans and Borrowings VRNA (Verona Pharma PLC)|Jyong Biotech Corp (MENS) - Company Long-Term Debt|Company Long-Term Liabilities Ligand Corp|AMRX (Amneal Pharmaceuticals) - Company Long-Term Debts|Company Long-Term Debts perrigo.com|Company Long-Term Liabilities ALVO (Alvotech SA)|LQDA (Liquidia Corp) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Galapagos Genomics GLPG|ANI Pharmaceuticals Corp (ANIP) - Long-Term Debt|MNKD: Company Long-Term Liabilities|amphastar.com - Amount of Long-Term Liabilities|PCRX: Company Long-Term Debts|ARS Pharmaceuticals Inc - Company Long-Term Loans and Borrowings|TBPH (Theravance) - Company Long-Term Debts|Long-Term Debt Aquestive Corp AQST|Company Long-Term Debt scPharmaceuticals Inc. (SCPH)|TECX (tectonictx.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Tonix Pharmaceuticals Holding Corp. TNXP|SXTC - Company Long-Term Liabilities|Eupraxia Pharma - Company Long-Term Debts|Long-Term Debt Volume BioHarvest Sciences Inc BHST|eXoZymes Inc (EXOZ) - Company Long-Term Debt|Company Long-Term Indebtedness ORMP|ENTX (Entera Bio Ltd) - Company Long-Term Debts|Company Long-Term Indebtedness ABVC (ABVC BioPharma Inc.)|Company Long-Term Liabilities CPIX (Cumberland Pharma)|Company Long-Term Liabilities Quantum BioPharma Corp QNTM|Company Long-Term Debts FGEN (FibroGen, Inc.)|Company Long-Term Debts telomirpharma.com TELO|RANI - Company Long-Term Debt|SNYR: Company Long-Term Debt|rallybio.com (RLYB) - Company Long-Term Debt|Lexaria Bioscience Corp. (LEXX) - Company Long-Term Debts|Company Long-Term Liabilities PULM|PTHL: Company Long-Term Loans and Borrowings|Company Long-Term Debts APM|LYRA (Lyra Therapeutics Inc.) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Impact BioMedical Inc IBO|TNF Pharmaceuticals Inc. (TNFA) - Long-Term Debt|YCBD - Company Long-Term Debt|PRFX: Company Long-Term Debt|CYTO: Company Long-Term Debts|Company Long-Term Indebtedness LIPO|OPTN (Optinose) - Company Long-Term Debts|Pieris Pharma (PIRS) - Long-Term Debt Volume|Company Long-Term Debt Procaps Group S.A. (PROC)|petrospharma.com - Company Long-Term Indebtedness|Company Long-Term Debts QLI (Qilian International Holding)|Long-Term Indebtedness Acelyrin Inc.|TFFP - Company Long-Term Debt